About Oxford Biodynamics
Oxford Biodynamics is a company based in Oxford (United Kingdom) founded in 2007.. Oxford Biodynamics has raised $11 million across 7 funding rounds from investors including FNIH. Oxford Biodynamics operates in a competitive market with competitors including Guardant Health, Foundation Medicine, ArcherDX, Metabolon and Natera, among others.
- Headquarter Oxford, United Kingdom
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Oxford Biodynamics Plc
-
Annual Revenue
$1.47 M (USD)72.17as on Sep 30, 2025
-
Net Profit
$-14.99 M (USD)3.58as on Sep 30, 2025
-
EBITDA
$-12.88 M (USD)13as on Sep 30, 2025
-
Total Equity Funding
$11 M (USD)
in 7 rounds
-
Latest Funding Round
$963 K (USD), Grant
May 03, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Oxford Biodynamics
Oxford Biodynamics is a publicly listed company on the LSE with ticker symbol OBD in UK, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Funding Insights of Oxford Biodynamics
Oxford Biodynamics has successfully raised a total of $11M across 7 strategic funding rounds. The most recent funding activity was a Grant round of $963 thousand completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 7
- Last Round Grant — $963,000
-
First Round
First Round
(01 Apr 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Grant - Oxford Biodynamics | Valuation |
investors |
|
| Oct, 2022 | Amount | Post-IPO - Oxford Biodynamics | Valuation |
investors |
|
| Nov, 2021 | Amount | Post-IPO - Oxford Biodynamics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Oxford Biodynamics
Oxford Biodynamics has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include FNIH. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Nonprofit organization funding NIH research in diseases like cancer and infectious diseases.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Oxford Biodynamics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Oxford Biodynamics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Oxford Biodynamics Comparisons
Competitors of Oxford Biodynamics
Oxford Biodynamics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Guardant Health, Foundation Medicine, ArcherDX, Metabolon and Natera, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Digital sequencing technology for cancer detection is developed.
|
|
| domain | founded_year | HQ Location |
Genomics-based diagnostic tests for cancer are provided.
|
|
| domain | founded_year | HQ Location |
Molecular cancer diagnostic products are developed using patented AMP technology.
|
|
| domain | founded_year | HQ Location |
Solutions for biomarker discovery and diagnostic testing are provided.
|
|
| domain | founded_year | HQ Location |
Developer of cell-free DNA testing for oncology, women’s health, and organ health
|
|
| domain | founded_year | HQ Location |
Provider of omics-based solutions for clinical genomics, systems biology, and drug discovery
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Oxford Biodynamics
Frequently Asked Questions about Oxford Biodynamics
When was Oxford Biodynamics founded?
Oxford Biodynamics was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Where is Oxford Biodynamics located?
Oxford Biodynamics is headquartered in Oxford, United Kingdom. It is registered at Oxford, Oxfordshire, United Kingdom.
Is Oxford Biodynamics a funded company?
Oxford Biodynamics is a funded company, having raised a total of $11M across 7 funding rounds to date. The company's 1st funding round was a Post-IPO of $5M, raised on Apr 01, 2009.
What is the annual revenue of Oxford Biodynamics?
Annual revenue of Oxford Biodynamics is $1.47M as on Sep 30, 2025.
What does Oxford Biodynamics do?
Oxford Biodynamics was founded in 2007 in Oxford, United Kingdom, and operates in the biotechnology sector focused on epigenetics. Personalized diagnostics are created by identifying biomarkers through the proprietary EpiSwitch platform, which enables early detection of aberrant gene expression in low copy numbers from small abnormal cell samples. Non-invasive tests are provided for conditions including Alzheimers Disease, Amyotrophic Lateral Sclerosis, Breast Cancer, and Type 1 Diabetes Mellitus.
Who are the top competitors of Oxford Biodynamics?
Oxford Biodynamics's top competitors include Guardant Health, Strand Life Sciences and Foundation Medicine.
Is Oxford Biodynamics publicly traded?
Yes, Oxford Biodynamics is publicly traded on LSE under the ticker symbol OBD.
Who are Oxford Biodynamics's investors?
Oxford Biodynamics has 1 investor. Key investors include FNIH.
What is Oxford Biodynamics's ticker symbol?
The ticker symbol of Oxford Biodynamics is OBD on LSE.